Browse studies, page 1226

Page 1226 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial Critical Care, 2020
• Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline Journal of Clinical Oncology, 2021
• Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? European Respiratory Review, 2020
• Bloodstream infections in critically ill patients with COVID‐19 European Journal of Clinical Investigation, 2020
• Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia BMC Infectious Diseases, 2020
• Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia Archives of Pediatrics and Adolescent Medicine, 2021
• Community-acquired pneumonia in critically ill very old patients: a growing problem European Respiratory Review, 2020
• Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China PLoS ONE, 2020
• Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia Stem Cell Research & Therapy, 2020
• Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China medRxiv, 2020
• Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China Journal of Medical Virology, 2020
• A Phase 2 Multicenter, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Reparixin in Hospitalized Adult Patients with COVID-19 Pneumonia C62. EXPANDING OUR INSIGHT INTO COVID-19, 2022
• Efficacy and Safety of Levamisole Treatment in Clinical Presentations of Patients With COVID-19: A Double-Blind, Randomized, Controlled Trial 2021
• Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial Trials, 2021
• Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial medRxiv, 2021
• Efficacy of clarithromycin on COVID-19 pneumonia without oxygen administration; protocol for multicenter, open-label, randomized-controlled, 3-armed parallel group comparison, exploratory trial (CAME COVID study) medRxiv, 2021
• A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial Trials, 2021
• Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia Infectious Disease and Therapy, 2022
• Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial PLoS ONE, 2022
• Efficacy of Oral Amoxicillin versus Parenteral Ceftriaxone in Treatment of Uncomplicated Community Acquired Pneumonia (CAP): A Prospective, Single Blinded, Parallel Design, Randomized Controlled Trial 2021
• Efficacy and Safety of Fixed Combination of Hydroxychloroquine with Azithromycin Versus Hydroxychloroquine and Placebo in Patients with Mild COVID-19: Randomized, double blind, Placebo controlled trial medRxiv, 2022
• Evaluation of the Efficacy and Safety of Intravenous Remdesivir in Adult Patients with Severe Pneumonia caused by COVID-19 virus Infection: study protocol for a Phase 3 Randomized, Double-blind, Placebo-controlled, Multicentre trial 2020
• Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia: a study protocol for a randomized controlled trial Trials, 2022
• Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial Medicine, 2022
• Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial Trials, 2020
• Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology Frontiers in Microbiology, 2025
• Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates Pathogens and Disease, 2024
• The Current Landscape of Phage–Antibiotic Synergistic (PAS) Interactions Antibiotics, 2025
• Multidrug resistant Acinetobacter baumannii: A study on its pathogenesis and therapeutics Current Research in Microbial Sciences, 2024
• Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities Journal of Medicinal Chemistry, 2024
• Applications of peptides in nanosystems for diagnosing and managing bacterial sepsis Journal of Biomedical Science, 2024
• Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents Toxins, 2025
• Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections BMC Biotechnology, 2024
• Exploring the potential of bis(thiazol-5-yl)phenylmethane derivatives as novel candidates against genetically defined multidrug-resistant Staphylococcus aureus PLoS ONE, 2024
• Population structure and antibiotic resistance of swine extraintestinal pathogenic Escherichia coli from China Nature Communications, 2024
• Novel Antibacterial Approaches and Therapeutic Strategies Antibiotics, 2025
• Therapeutic Potential of Cinnamon Oil: Chemical Composition, Pharmacological Actions, and Applications Pharmaceuticals, 2024
• Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication ACS Omega, 2025
• Opportunities for Helicobacter pylori Eradication beyond Conventional Antibiotics Microorganisms, 2024
• Genome analyses of colistin-resistant high-risk blaNDM-5 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings BMC Microbiology, 2024
• Distribution and genetic characterization of fluoroquinolone resistance gene qnr among Salmonella strains from chicken in China Microbiology Spectrum, 2024
• Polyphenolic compounds in Glycyrrhiza spp.: a potential weapon against multidrug-resistant pathogens Frontiers in Pharmacology, 2026
• Analysis of ICU resistome dynamics in patients, staff and environment for the identification of predictive biomarkers of sepsis and early mortality Scientific Reports, 2025
• The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields Drug Target Insights, 2024
• A survey of isatin hybrids and their biological properties Molecular Diversity, 2024
• Turning the Tide Against Carbapenem-resistant Acinetobacter baumannii : Advancing Care With Sulbactam–Durlobactam Open Forum Infectious Diseases, 2025
• Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions Pharmaceutics, 2024
• Bromhexine hydrochloride enhances the therapeutic efficacy of tiamulin against experimental Staphylococcus aureus infection in dogs: targeting bacterial virulence, boosting antioxidant defense, and improving histopathology Frontiers in Pharmacology, 2025
• Discovery of Broad‐Spectrum Repurposed Drug Combinations Against Carbapenem‐Resistant Enterobacteriaceae (CRE) Through Artificial Intelligence (AI)‐Driven Platform Advanced Therapeutics, 2024
• Antimicrobial activity and mechanistic insights of AMP-17 against drug-resistant Pseudomonas aeruginosa and its efficacy in wound infection management Frontiers in Cellular and Infection Microbiology, 2025
• Nanoformulations Loaded with Phytochemicals for Combating Wound Infections and Promoting Wound Healing: Current Applications and Innovations Applied Sciences, 2025
• Deciphering Multidrug-Resistant Pseudomonas aeruginosa: Mechanistic Insights and Environmental Risks Toxics, 2025
• Chitosan-based formulations for therapeutic applications. A recent overview Journal of Biomedical Science, 2025
• New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections Microorganisms, 2025
• Clinical Trial Findings and Drug Development Challenges for Curcumin in Infectious Disease Prevention and Treatment Life, 2024
• Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end? Malaria Journal, 2024
• Mortality outcomes of extended-spectrum β-lactamase in bacteremia with carbapenems and other antibiotics: A systematic review Journal of Advanced Pharmaceutical Technology amp Research, 2025
• Hospital-acquired pneumonia: a narrative review 2026
• Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology Journal of Antimicrobial Chemotherapy, 2025
• Strategies for Tuberculosis Prevention in Healthcare Settings: A Narrative Review Tropical Medicine and Infectious Disease, 2025
• The effect of periodontal treatment on Helicobacter pylori-infection: a systematic review Periodontal and Implant Research, 2025
• Global trends in macrolide and lincosamide resistance in Streptococcus species: a comprehensive systematic review and meta-analysis BMC Infectious Diseases, 2025
• Advances in Understanding Recurrent Pulmonary Infections Following Foreign Body Aspiration: A Narrative Review Journal of Asthma and Allergy, 2025
• Nephrotoxicity of New Antibiotics: A Systematic Review Toxics, 2025
• Comparative Effectiveness of Single, Dual, and Multi-Antibiotic Therapies in Managing Carbapenem-Resistant Enterobacterales: A Systematic Review and Meta-Analysis on Survival Rates Trends in Sciences, 2025
• Association of variant vitamin statuses and tuberculosis development: a systematic review and meta-analysis Annals of Medicine, 2024
• Protegrin-1 and Analogues Against Acinetobacter baumannii: A Narrative Review Pharmaceuticals, 2025
• The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review Journal of Clinical Medicine, 2025
• Structural and functional diversity of Resistance-Nodulation-Division (RND) efflux pump transporters with implications for antimicrobial resistance Microbiology and Molecular Biology Reviews, 2024
• Incidence and influencing factors of tooth discoloration in children using doxycycline: a meta-analysis Frontiers in Pediatrics, 2025
• Actively Targeted Nanoparticles for Enhanced Diagnosis, Treatment, and Vaccination of Tuberculosis: A Systematic Review International Journal of Nanomedicine, 2025
• Global Epidemiology and Antimicrobial Resistance of Metallo-β-Lactamase (MBL)-Producing Acinetobacter Clinical Isolates: A Systematic Review Pathogens, 2025
• Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis Infectious Diseases and Therapy, 2024
• Antibiotic Resistance in Klebsiella pneumoniae in Iraq: A Narrative Review Journal of Life and Bio Sciences Research, 2025
• Nano-scaffold-based delivery systems of antimicrobial agents in the treatment of osteomyelitis ; a narrative review Heliyon, 2024
• A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Journal of Clinical Laboratory Analysis, 2024
• N-acetylcysteine as a promising treatment for COVID-19: A comprehensive meta-analysis of systemic manifestations and clinical outcomes Italian Journal of Food Science, 2025
• Anthrax: A narrative review New Microbes and New Infections, 2024
• Effectiveness of Bairui granules in the treatment of respiratory tract infections: A systematic review and meta-analysis Medicine, 2024
• Bacterial Infections and Antibiotic Sensitivity Patterns in Cancer Patients: A Systematic Review African Journal of Biomedical Research, 2024
• Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort Esophagus, 2024
• Real-World Outcomes and Prognostic Factors of Polymyxin B Hemoperfusion in Severe Sepsis and Septic Shock: A Seven-Year Single-Center Cohort Study from Taiwan Life, 2025
• Comparative real-world safety of nivolumab versus pembrolizumab in malignant melanoma: A propensity-matched cohort study Journal of Clinical Oncology, 2026
• Exploring Clinical Characteristics and Risk Factors of Mycoplasma pneumoniae-Induced Segmental/Lobar Pneumonia in Chongqing, China, During 2023: A Single-Center Retrospective Cohort Study of Hospitalized Children Journal of Inflammation Research, 2026
• Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study Infectious Disease and Therapy, 2024
• Efficacy of Inhaled Colistin in Critically Ill Children with Ventilator-Associated Pneumonia Resistant to Multiple Drugs Journal of Comprehensive Pediatrics, 2024
• The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes Antibiotics, 2024
• The Efficacy and Safety of Homoharringtonine Added to Venetoclax and Azacitidine in the Frontline Treatment of Newly Diagnosed Acute Myeloid Leukemia, a Multi-Center Exploratory Cohort Study Blood, 2024
• Treatment of Renal Artery Aneurysm by ex situ Repair and Autotransplantation: A Nationwide Cohort Study European Surgical Research, 2024
• A comprehensive analysis of in-hospital adverse events after scopolamine administration: insights from a retrospective cohort study using a large nationwide inpatient database BMC Anesthesiology, 2024
• Injectable Particulated Human Acellular Dermal Matrix Booster for Skin Restoration: An Integrated Randomized, Split-Face, Double-Blinded Clinical Trial and Preclinical Study International Journal of Molecular Sciences, 2026
• Effects of Allium fistulosum L. (Green Onion) Root and Avena sativa L. (Oat) Mixtures (WCO31) on the Height of Children: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Nutrients, 2026
• FDA: Silicone Breast Implants Seem Safe Rheumatology News, 2011
• Recent Advances in the Management of AIDS-related Opportunistic Infections Annals of Internal Medicine, 1994
• SARS Patients and Need for Treatment Emerging Infectious Diseases, 2004
• Ventilator-Associated Pneumonia Caused by Pseudomonas aeruginosa: Cap Your Needles! Critical Care Medicine, 2012
• Roles of the clinical pharmacist during the COVID‐19 pandemic Journal of the American College of Clinical Pharmacy, 2020
• Novel Therapeutic Interventions in Treating Patients with COVID-19 Pneumonia, COVID-19 Acute Respiratory Syndrome and Severe COVID-19 Illness and Promising Vaccine Candidates ACTA SCIENTIFIC MICROBIOLOGY, 2020
• Turning the Phage on Treatment of Antimicrobial-Resistant Pneumonia American Journal of Respiratory and Critical Care Medicine, 2019
• Sulfonylurea drugs for people with severe hemispheric ischemic stroke Cochrane Database of Systematic Reviews, 2025